Filtros de búsqueda

Lista de obras de Cyril Quivoron

A small molecule inhibitor of mutant IDH2 rescues cardiomyopathy in a D-2-hydroxyglutaric aciduria type II mouse model.

artículo científico publicado en 2016

AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations.

artículo científico publicado en 2017

B-cell tumor development in -deficient mice

article

Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib

scientific article published on 16 July 2018

Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers.

artículo científico publicado en 2018

Isocitrate dehydrogenase (IDH)2 R140Q mutation induces myeloid and lymphoid neoplasms in mice

artículo científico publicado en 2014

Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations

artículo científico publicado en 2018

Quantitation of isocitrate dehydrogenase (IDH)-induced D and L enantiomers of 2-hydroxyglutaric acid in biological fluids by a fully validated liquid tandem mass spectrometry method, suitable for clinical applications

artículo científico publicado en 2016

Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group.

artículo científico publicado en 2013

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis

scientific journal article

TET2, a tumor suppressor in hematological disorders.

artículo científico

Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation

artículo científico publicado en 2013

[In cauda venenum or the importance of TET(2)]

scientific article published on 23 December 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda